Lawrence B. Cohen’s Biogen BIIB Stock Holding History

Lawrence B. Cohen’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,093	Closed	-$1.68M	–	74
2019 Q1	$1.68M	Sell	7,093 -450	-6%	-$142K	1.18%	35
2018 Q4	$2.27M	Sell	7,543 -86	-1%	-$27.4K	1.76%	26
2018 Q3	$2.69M	Sell	7,629 -583	-7%	-$201K	1.83%	24
2018 Q2	$2.38M	Sell	8,212 -1,498	-15%	-$421K	1.71%	27
2018 Q1	$2.66M	Buy	9,710 +95	+1%	+$29.5K	1.78%	25
2017 Q4	$3.06M	Sell	9,615 -65	-0.7%	-$20.9K	1.94%	25
2017 Q3	$3.03M	Buy	9,680 +85	+0.9%	+$25.2K	1.97%	25
2017 Q2	$2.6M	Buy	9,595 +1,005	+12%	+$266K	1.66%	25
2017 Q1	$2.35M	Buy	8,590 +465	+6%	+$131K	1.45%	26
2016 Q4	$2.3M	Buy	8,125 +1,330	+20%	+$394K	1.4%	27
2016 Q3	$2.13M	Buy	6,795 +915	+16%	+$271K	1.27%	29
2016 Q2	$1.42M	Buy	+5,880	New	+$1.55M	0.85%	34

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lawrence B. Cohen's BIIB Position: Q2 2019 in Review

Lawrence B. Cohen sold out of Biogen (BIIB) in Q2 2019, closing a stake of 7,093 shares — an estimated $1.68M sold.

Lawrence B. Cohen first reported a position in BIIB in Q2 2016 and held it in 12 quarters. The position peaked at $3.06M in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Lawrence B. Cohen reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Lawrence B. Cohen sold 7,093 Biogen shares in Q2 2019, an estimated $1.68M.
Lawrence B. Cohen first reported a position in Biogen in Q2 2016 and held it in 12 quarters.
Lawrence B. Cohen's Biogen position peaked at $3.06M in Q4 2017.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Lawrence B. Cohen's 13F filing for Q2 2019, filed 1 Aug 2019.